Delivery Order SPE2DB22D3501-SPE2DB23FWR76
Award Date 8/1/23
Potential Completion Date 8/2/23
Potential Value $31
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $31,000 to Amerisourcebergen Drug Corporation for the supply of docetaxel, an oncology drug. The delivery order was issued under an existing prime vendor contract held by Amerisourcebergen Corporation to provide pharmaceutical products and services to military treatment facilities for the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $54,620 under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is to provide 160 mg/8 ml vials of the chemotherapy drug docetaxel for the period of August 28-29, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency functions to support the resupply needs of the U.S. military...
- The Defense Logistics Agency awarded a $54,620 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 160 mg/8 ml vials of docetaxel. The single delivery order was issued under an existing prime vendor contract vehicle and requires Amerisourcebergen to deliver the chemotherapy drug to a facility in Conshohocken, Pennsylvania by July 25, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-eight thousand nine hundred ninety-five dollars to Amerisourcebergen Drug Corporation for the supply of four hundred eighty milligrams of docetaxel in four milliliter vials. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 29, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately thirty-nine thousand dollars to Amerisourcebergen Drug Corporation for docetaxel, an oncology drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day in September 2023. As a major supplier of pharmaceuticals to the Department of Defense, this order for docetaxel is consistent with DLA's role in supporting the military health system and...
- The Defense Logistics Agency awarded a delivery order valued at $1,907.43 to AmerisourceBergen Drug Corp for the supply of Docetaxel 80 mg/4 ml vials on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-one thousand nine dollars to Amerisourcebergen Drug Corporation for the supply of four hundred eighty milligrams of docetaxel in four milliliter vials. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania by September 20, 2023 in support of the Defense Logistics Agency's medical supply needs. No...
- The Defense Logistics Agency awarded a $557 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 160 mg/16 ml vials of docetaxel, an oncology drug. The order is under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceuticals and medical supplies to DOD and other federal agencies. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 21-24, 2023. No...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at three hundred twenty-six dollars and forty cents to Amerisourcebergen Drug Corporation for the supply of eight milliliter vials containing eighty milligrams of docetaxel. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in mid-August 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation, a major...
- The Defense Logistics Agency awarded a $3,632.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561354192, described as 160 mg/16 ml vials of docetaxel in 16 ml quantities. Performance will take place in Conshohocken, Pennsylvania from June 27-28, 2023. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the chemotherapy drug to the Defense Logistics Agency, the logistics combat support agency within the...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWR76Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-one thousand nine dollars to Amerisourcebergen Drug Corporation for the supply of four hundred eighty milliliters of docetaxel, an oncology drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania under the period of performance of August 1st through August 2nd, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order for a chemotherapy medication supports the Agency's mission to provide critical healthcare commodities to military treatment facilities and beneficiaries.
Generated 12/24/23, 3:39 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31 | 8/1/23 |